Found: 82
Select item for more details and to access through your institution.
Use of systemic antifungals in daily clinical practice in the haematology and oncology setting: results of a prospective observational analysis.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2012, v. 21, n. 9, p. 953, doi. 10.1002/pds.3278
- By:
- Publication type:
- Article
Clinical phenotype and outcome of persistent SARS-CoV-2 replication in immunocompromised hosts: a retrospective observational study in the Omicron era.
- Published in:
- Infection, 2024, v. 52, n. 3, p. 923, doi. 10.1007/s15010-023-02138-0
- By:
- Publication type:
- Article
COVID-19 pneumonia in a multiple sclerosis patient with severe lymphopenia due to recent cladribine treatment.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 10, p. 1264, doi. 10.1177/1352458520943783
- By:
- Publication type:
- Article
Impact of prior treatment on selinexor, bortezomib, dexamethasone outcomes in patients with relapsed/refractory multiple myeloma: Extended follow‐up subgroup analysis of the BOSTON trial.
- Published in:
- European Journal of Haematology, 2024, v. 113, n. 2, p. 242, doi. 10.1111/ejh.14223
- By:
- Publication type:
- Article
Identification of clinical factors impacting outcome in patients undergoing autologous hematopoietic cell transplantation after BEAM and TEAM conditioning.
- Published in:
- European Journal of Haematology, 2024, v. 112, n. 3, p. 350, doi. 10.1111/ejh.14118
- By:
- Publication type:
- Article
Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide‐pretreated myeloma: A subanalysis of OPTIMISMM by clinical characteristics.
- Published in:
- European Journal of Haematology, 2022, v. 108, n. 1, p. 73, doi. 10.1111/ejh.13706
- By:
- Publication type:
- Article
Full or intensity‐reduced high‐dose melphalan and single or double autologous stem cell transplant with or without bortezomib consolidation in patients with newly diagnosed multiple myeloma.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 5, p. 529, doi. 10.1111/ejh.13690
- By:
- Publication type:
- Article
Bortezomib consolidation following autologous transplant in younger and older patients with newly diagnosed multiple myeloma in two phase III trials.
- Published in:
- European Journal of Haematology, 2019, v. 103, n. 3, p. 255, doi. 10.1111/ejh.13281
- By:
- Publication type:
- Article
The serum heavy/light chain immunoassay: A valuable tool for sensitive paraprotein assessment, risk, and disease monitoring in monoclonal gammopathies.
- Published in:
- European Journal of Haematology, 2017, v. 99, n. 5, p. 449, doi. 10.1111/ejh.12958
- By:
- Publication type:
- Article
Real-World Evaluation of Health-Related Quality of Life in Patients With Multiple Myeloma From Germany.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Dapsone-Induced Hemolytic Anemia in Multiple Myeloma: Case Report of Various Differential Diagnoses.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Carfilzomib, bendamustine, dexamethasone in patients with advanced multiple myeloma: The EMN09 Phase I/II study of the European Myeloma Network.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e256, doi. 10.1016/j.clml.2019.09.424
- By:
- Publication type:
- Article
Pomalidomide + Bortezomib + Dexamethasone After One Prior Line of Therapy in Bortezomib-Pretreated Multiple Myeloma: Subanalysis of OPTIMISMM.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e32, doi. 10.1016/j.clml.2019.09.048
- By:
- Publication type:
- Article
Cast Nephropathy and Deceptively Low Absolute Serum Free Light Chain Levels: Resolution of a Challenging Case and Systematic Review of the Literature.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A phase I/IIa Study of the CD38 Antibody MOR202 in Combination With Pomalidomide or Lenalidomide in Patients With Relapsed or Refractory Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e61, doi. 10.1016/j.clml.2017.03.112
- By:
- Publication type:
- Article
A Multicenter Phase I/II EMN Study of Carfilzomib in Combination with Bendamustine and Dexamethasone (CBd) in Relapsed and/or Refractory Patients with Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e125, doi. 10.1016/j.clml.2017.03.227
- By:
- Publication type:
- Article
Multiple myeloma and second malignancies.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Validation of the Freiburg Comorbidity Index in 466 Multiple Myeloma Patients and Combination With the International Staging System Are Highly Predictive for Outcome.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 5, p. 541, doi. 10.1016/j.clml.2013.03.013
- By:
- Publication type:
- Article
Prognostic Risk Factor Evaluation in Patients With Relapsed or Refractory Multiple Myeloma Receiving Lenalidomide Treatment: Analysis of Renal Function by eGFR and of Additional Comorbidities by Comorbidity Appraisal.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2012, v. 12, n. 1, p. 38, doi. 10.1016/j.clml.2011.09.216
- By:
- Publication type:
- Article
The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic review.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-022-00779-2
- By:
- Publication type:
- Article
Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 12, p. 1, doi. 10.1038/s41408-021-00587-0
- By:
- Publication type:
- Article
Cytogenetics of extramedullary manifestations in multiple myeloma.
- Published in:
- British Journal of Haematology, 2013, v. 161, n. 1, p. 87, doi. 10.1111/bjh.12223
- By:
- Publication type:
- Article
Potent in vitro and in vivo activity of sorafenib in multiple myeloma: induction of cell death, CD138-downregulation and inhibition of migration through actin depolymerization.
- Published in:
- British Journal of Haematology, 2013, v. 161, n. 1, p. 104, doi. 10.1111/bjh.12226
- By:
- Publication type:
- Article
Bortezomib in combination with intermediate-dose dexamethasone and continuous low-dose oral cyclophosphamide for relapsed multiple myeloma.
- Published in:
- British Journal of Haematology, 2007, v. 138, n. 3, p. 330, doi. 10.1111/j.1365-2141.2007.06656.x
- By:
- Publication type:
- Article
Telomere maintenance in human B lymphocytes.
- Published in:
- British Journal of Haematology, 2002, v. 119, n. 3, p. 810, doi. 10.1046/j.1365-2141.2002.03910.x
- By:
- Publication type:
- Article
Multidisciplinary tumor boards and their analyses: the yin and yang of outcome measures.
- Published in:
- 2021
- By:
- Publication type:
- letter
Posaconazole Therapeutic Drug Monitoring in the Real-life Setting: A Single-Center Experience and Review of the Literature.
- Published in:
- Pharmacotherapy, 2013, v. 33, n. 10, p. 1117, doi. 10.1002/phar.1328
- By:
- Publication type:
- Article
Pomalidomide combinations are a safe and effective option after daratumumab failure.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 9, p. 6569, doi. 10.1007/s00432-023-04637-x
- By:
- Publication type:
- Article
Ex vivo propagation in a novel 3D high-throughput co-culture system for multiple myeloma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 5, p. 1045, doi. 10.1007/s00432-021-03854-6
- By:
- Publication type:
- Article
Whole-body MRI in the detection of bone marrow infiltration in patients with plasma cell neoplasms in comparison to the radiological skeletal survey.
- Published in:
- 2006
- By:
- Publication type:
- journal article
The Changing Landscape of Smoldering Multiple Myeloma: A European Perspective.
- Published in:
- Oncologist, 2016, v. 21, n. 3, p. 333, doi. 10.1634/theoncologist.2015-0303
- By:
- Publication type:
- Article
Covid‐19 in patients with hematological and solid cancers at a Comprehensive Cancer Center in Germany.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 22, p. 8412, doi. 10.1002/cam4.3460
- By:
- Publication type:
- Article
Detection of renal impairment as one specific comorbidity factor in multiple myeloma: multicenter study in 198 consecutive patients.
- Published in:
- European Journal of Haematology, 2009, v. 83, n. 6, p. 519, doi. 10.1111/j.1600-0609.2009.01318.x
- By:
- Publication type:
- Article
Myelodysplastic syndrome in transformation to acute myeloid leukemia presenting with diabetes insipidus: due to pituitary infiltration association with abnormalities of chromosomes 3 and 7.
- Published in:
- European Journal of Haematology, 2002, v. 69, n. 2, p. 115, doi. 10.1034/j.1600-0609.2002.02763.x
- By:
- Publication type:
- Article
Intratibial Injection of Human Multiple Myeloma Cells in NOD/SCID IL-2Rγ(Null) Mice Mimics Human Myeloma and Serves as a Valuable Tool for the Development of Anticancer Strategies.
- Published in:
- PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0079939
- By:
- Publication type:
- Article
The 3' Untranslated Region of the Cyclin B mRNA Is Not Sufficient to Enhance the Synthesis of Cyclin B during a Mitotic Block in Human Cells.
- Published in:
- PLoS ONE, 2013, v. 8, n. 9, p. 1, doi. 10.1371/journal.pone.0074379
- By:
- Publication type:
- Article
Interprofessional Medication Management in Patients With Multiple Morbidities--A Clusterrandomized Trial (the WestGem Study).
- Published in:
- 2017
- By:
- Publication type:
- Letter to the Editor
The Prevention of Medication-related Osteonecrosis of the Jaw.
- Published in:
- Deutsches Ärzteblatt International, 2017, v. 114, n. 5, p. 63, doi. 10.3238/arztebl.2017.0063
- By:
- Publication type:
- Article
Comparison of the prognostic significance of 5 comorbidity scores and 12 functional tests in a prospective multiple myeloma patient cohort.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 18, p. 3422, doi. 10.1002/cncr.33658
- By:
- Publication type:
- Article
Carfilzomib, bendamustine, and dexamethasone in patients with advanced multiple myeloma: The EMN09 phase 1/2 study of the European Myeloma Network.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 18, p. 3413, doi. 10.1002/cncr.33647
- By:
- Publication type:
- Article
Risk of disease recurrence and survival in patients with multiple myeloma: A German Study Group analysis using a conditional survival approach with long-term follow-up of 815 patients.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Avoiding chemotherapy prescribing errors: Analysis and innovative strategies.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Favourable outcomes of double‐hit/double‐expressor lymphoma and high‐grade B‐cell lymphoma, not otherwise specified after early dose‐intensive treatment and up‐front autologous stem cell transplantation: a single‐centre retrospective experience
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 4, p. 776, doi. 10.1111/bjh.18280
- By:
- Publication type:
- Article
Expert review on soft‐tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations.
- Published in:
- British Journal of Haematology, 2021, v. 194, n. 3, p. 496, doi. 10.1111/bjh.17338
- By:
- Publication type:
- Article
Phase II study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: DSMM XI trial.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 4, p. 586, doi. 10.1111/bjh.14920
- By:
- Publication type:
- Article
CXCL12 and CXCR7 are relevant targets to reverse cell adhesion-mediated drug resistance in multiple myeloma.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 1, p. 36, doi. 10.1111/bjh.14807
- By:
- Publication type:
- Article
Favourable outcomes of poor prognosis diffuse large B-cell lymphoma patients treated with dose-dense Rituximab, high-dose Methotrexate and six cycles of CHOP-14 compared to first-line autologous transplantation.
- Published in:
- British Journal of Haematology, 2017, v. 178, n. 6, p. 927, doi. 10.1111/bjh.14802
- By:
- Publication type:
- Article
From CLL to Multiple Myeloma - Spleen Tyrosine Kinase ( SYK) influences multiple myeloma cell survival and migration.
- Published in:
- British Journal of Haematology, 2016, v. 174, n. 6, p. 985, doi. 10.1111/bjh.13825
- By:
- Publication type:
- Article
The Role of the APC/C and Its Coactivators Cdh1 and Cdc20 in Cancer Development and Therapy.
- Published in:
- Frontiers in Genetics, 2022, v. 13, p. 1, doi. 10.3389/fgene.2022.941565
- By:
- Publication type:
- Article
Empirical caspofungin therapy in clinical practice for suspected invasive fungal disease in adults with acute lymphoblastic leukaemia.
- Published in:
- Mycoses, 2015, v. 58, n. 2, p. 76, doi. 10.1111/myc.12277
- By:
- Publication type:
- Article